These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27522158)

  • 1. Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.
    Povsic TJ; Lawrence MG; Lincoff AM; Mehran R; Rusconi CP; Zelenkofske SL; Huang Z; Sailstad J; Armstrong PW; Steg PG; Bode C; Becker RC; Alexander JH; Adkinson NF; Levinson AI;
    J Allergy Clin Immunol; 2016 Dec; 138(6):1712-1715. PubMed ID: 27522158
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer.
    Ganson NJ; Povsic TJ; Sullenger BA; Alexander JH; Zelenkofske SL; Sailstad JM; Rusconi CP; Hershfield MS
    J Allergy Clin Immunol; 2016 May; 137(5):1610-1613.e7. PubMed ID: 26688515
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers.
    Moreno A; Pitoc GA; Ganson NJ; Layzer JM; Hershfield MS; Tarantal AF; Sullenger BA
    Cell Chem Biol; 2019 May; 26(5):634-644.e3. PubMed ID: 30827937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate-type hypersensitivity to polyethylene glycols: a review.
    Wenande E; Garvey LH
    Clin Exp Allergy; 2016 Jul; 46(7):907-22. PubMed ID: 27196817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG.
    Radice A; Fassio F; Meucci E; Iorno MCL; Macchia D
    Eur Ann Allergy Clin Immunol; 2021 Sep; 53(5):240-242. PubMed ID: 33913314
    [No Abstract]   [Full Text] [Related]  

  • 6. Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal Testing.
    Pickert J; Hennighausen I; Mühlenbein S; Möbs C; Pfützner W
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):526-527. PubMed ID: 34132638
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of polyethylene glycol-induced histamine release by monomeric ethylene and diethylene glycol: a case of probable polyethylene glycol allergy.
    Wenande EC; Skov PS; Mosbech H; Poulsen LK; Garvey LH
    J Allergy Clin Immunol; 2013 May; 131(5):1425-7. PubMed ID: 23228247
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a.
    White JT; Crossman M; Richter K; Berman M; Goyal J; Subramanyam M
    Bioanalysis; 2015 Nov; 7(21):2801-11. PubMed ID: 26541956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel PEGylation Method for Improving the Pharmacokinetic Properties of Anti-Interleukin-17A RNA Aptamers.
    Haruta K; Otaki N; Nagamine M; Kayo T; Sasaki A; Hiramoto S; Takahashi M; Hota K; Sato H; Yamazaki H
    Nucleic Acid Ther; 2017 Feb; 27(1):36-44. PubMed ID: 27827561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of chronic hepatitis C with pegylated interferon alfa-2a].
    Berg T
    Z Gastroenterol; 2001 Jul; 39(7):551-4. PubMed ID: 11505337
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrogol hypersensitivity in multiple drug allergy.
    Bommarito L; Mietta S; Nebiolo F; Geuna M; Rolla G
    Ann Allergy Asthma Immunol; 2011 Dec; 107(6):542-3. PubMed ID: 22123387
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics.
    Verhoef JJ; Carpenter JF; Anchordoquy TJ; Schellekens H
    Drug Discov Today; 2014 Dec; 19(12):1945-52. PubMed ID: 25205349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated liposomal doxorubicin: a guide to its use in various malignancies.
    Lyseng-Williamson KA; Duggan ST; Keating GM
    BioDrugs; 2013 Oct; 27(5):533-40. PubMed ID: 24018470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly.
    Pidaparti M; Bostrom B
    Pediatr Blood Cancer; 2012 Sep; 59(3):436-9. PubMed ID: 22021170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacing antibodies with modified DNA aptamers in vaccine potency assays.
    Trausch JJ; Shank-Retzlaff M; Verch T
    Vaccine; 2017 Oct; 35(41):5495-5502. PubMed ID: 28433327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retargeting pre-existing human antibodies to a bacterial pathogen with an alpha-Gal conjugated aptamer.
    Kristian SA; Hwang JH; Hall B; Leire E; Iacomini J; Old R; Galili U; Roberts C; Mullis KB; Westby M; Nizet V
    J Mol Med (Berl); 2015 Jun; 93(6):619-31. PubMed ID: 25940316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of an Allergen-Antibody Reaction Related to Japanese Cedar Pollinosis Using DNA Aptamers Against the Cry j 2 Allergen.
    Ogihara K; Savory N; Abe K; Yoshida W; Arakawa M; Asahi M; Kamohara S; Ikebukuro K
    Nucleic Acid Ther; 2015 Dec; 25(6):311-6. PubMed ID: 26484654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician Awareness of Immune Responses to Polyethylene Glycol-Drug Conjugates.
    McSweeney MD; Versfeld ZC; Carpenter DM; Lai SK
    Clin Transl Sci; 2018 Mar; 11(2):162-165. PubMed ID: 29383836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity to polyethylene glycols.
    Shah S; Prematta T; Adkinson NF; Ishmael FT
    J Clin Pharmacol; 2013 Mar; 53(3):352-5. PubMed ID: 23444288
    [No Abstract]   [Full Text] [Related]  

  • 20. Certolizumab pegol: in Crohn's disease.
    Blick SK; Curran MP
    BioDrugs; 2007; 21(3):195-201; discussion 202-3. PubMed ID: 17516714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.